newsfilter
← Latest News
GlobeNewswire·

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update Landmark deal announced with Takeda for ACI-24.060 with $100 million upfront and total potential payments for option exercise and